116 related articles for article (PubMed ID: 37121538)
1. ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression.
An X; Wu W; Yang L; Dong J; Liu B; Guo J; Chen J; Guo B; Cao W; Jiang Q
Transl Res; 2023 Sep; 259():62-71. PubMed ID: 37121538
[TBL] [Abstract][Full Text] [Related]
2. METTL3 Promotes Osteosarcoma Metastasis via an m6A-dependent Epigenetic Activity of CBX4.
Huo XS; Lu D; Chen DG; Ye M; Wang XW; Shang FS
Front Biosci (Landmark Ed); 2024 Mar; 29(3):120. PubMed ID: 38538251
[TBL] [Abstract][Full Text] [Related]
3. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.
Ni WJ; Zhou H; Lu H; Ma NN; Hou BB; Li W; Kong FX; Yu JT; Hou R; Jin J; Wen JG; Zhang T; Meng XM
Clin Transl Med; 2023 Aug; 13(8):e1359. PubMed ID: 37537731
[TBL] [Abstract][Full Text] [Related]
4. METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility.
Li X; Jin J; Long X; Weng R; Xiong W; Liang J; Liu J; Sun J; Cai X; Zhang L; Liu Y
Reprod Biol Endocrinol; 2023 Oct; 21(1):99. PubMed ID: 37891533
[TBL] [Abstract][Full Text] [Related]
5. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase.
Ping XL; Sun BF; Wang L; Xiao W; Yang X; Wang WJ; Adhikari S; Shi Y; Lv Y; Chen YS; Zhao X; Li A; Yang Y; Dahal U; Lou XM; Liu X; Huang J; Yuan WP; Zhu XF; Cheng T; Zhao YL; Wang X; Rendtlew Danielsen JM; Liu F; Yang YG
Cell Res; 2014 Feb; 24(2):177-89. PubMed ID: 24407421
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA TUG1 promotes malignant progression of osteosarcoma by enhancing ZBTB7C expression.
An X; Wu W; Wang P; Mahmut A; Guo J; Dong J; Gong W; Liu B; Yang L; Ma Y; Xu X; Chen J; Cao W; Jiang Q
Biomed J; 2023 Aug; ():100651. PubMed ID: 37562773
[TBL] [Abstract][Full Text] [Related]
7. METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma.
Zhang Z; Fu J; Zhang Y; Qin X; Wang Y; Xing C
BMC Gastroenterol; 2023 Jun; 23(1):217. PubMed ID: 37344779
[TBL] [Abstract][Full Text] [Related]
8. METTL3 Mediated MALAT1 m6A Modification Promotes Proliferation and Metastasis in Osteosarcoma Cells.
Zhang Y; Xu Y; Qiu G; Luo Y; Bao Y; Lu J; Wang T; Wang Y
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37897586
[TBL] [Abstract][Full Text] [Related]
9. METTL3 Affects Spinal Cord Neuronal Apoptosis by Regulating Bcl-2 m6A Modifications After Spinal Cord Injury.
Guo S; Lin T; Chen G; Shangguan Z; Zhou L; Chen Z; Shi T; Chen D; Wang Z; Liu W
Neurospine; 2023 Jun; 20(2):623-636. PubMed ID: 37401082
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of Chrna4 by METTL3-mediated m6A modification participates in BPA-induced spatial memory deficit.
Li D; Huang C; Liu Z; Ai S; Wang HL
Environ Res; 2023 Nov; 236(Pt 1):116717. PubMed ID: 37495067
[TBL] [Abstract][Full Text] [Related]
11. m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2.
Huang X; Yang Z; Li Y; Long X
Ann Hematol; 2023 Jul; 102(7):1801-1810. PubMed ID: 37222774
[TBL] [Abstract][Full Text] [Related]
12. METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing.
Wang X; Wang J; Zhao X; Wu H; Li J; Cheng Y; Guo Q; Cao X; Liang T; Sun L; Zhang G
J Transl Med; 2023 Jun; 21(1):407. PubMed ID: 37353804
[TBL] [Abstract][Full Text] [Related]
13. METTL3 suppresses invasion of lung cancer via SH3BP5 m6A modification.
Zhang B; Qian R; Li X
Arch Biochem Biophys; 2024 Feb; 752():109876. PubMed ID: 38141906
[TBL] [Abstract][Full Text] [Related]
14. METTL3-Mediated RNA m6A Modification Regulates the Angiogenic Behaviors of Retinal Endothelial Cells by Methylating MMP2 and TIE2.
Lin Y; Luo G; Liu Q; Yang R; Sol Reinach P; Yan D
Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):18. PubMed ID: 37819742
[TBL] [Abstract][Full Text] [Related]
15. METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL.
Wu Y; Jin M; Fernandez M; Hart KL; Liao A; Ge X; Fernandes SM; McDonald T; Chen Z; Röth D; Ghoda LY; Marcucci G; Kalkum M; Pillai RK; Danilov AV; Li JJ; Chen J; Brown JR; Rosen ST; Siddiqi T; Wang L
Blood Cancer Discov; 2023 May; 4(3):228-245. PubMed ID: 37067905
[TBL] [Abstract][Full Text] [Related]
16. METTL3-mediated m
Wang W; Ye W; Chen S; Tang Y; Chen D; Lu Y; Wu Z; Huang Z; Ge Y
Cell Signal; 2023 Sep; 109():110784. PubMed ID: 37356601
[TBL] [Abstract][Full Text] [Related]
17. Modulating the m6A Modified Transcription Factor GATA6 Impacts Epithelial Cytokines in Acute Lung Injury.
Jin A; Li L; Zhao Y; Li M; Zhang S; Chen J; Li Y; Huang L; Ren H; Lu S; Yang X; Sun Q
Am J Respir Cell Mol Biol; 2023 Nov; 69(5):521-532. PubMed ID: 37494067
[TBL] [Abstract][Full Text] [Related]
18. METTL3 Reduces Oxidative Stress-induced Apoptosis in Presbycusis by Regulating the N6-methyladenosine Level of SIRT1 mRNA.
Wang E; Li Y; Li H; Liu Y; Ming R; Wei J; Du P; Li X; Zong S; Xiao H
Neuroscience; 2023 Jun; 521():110-122. PubMed ID: 37087022
[TBL] [Abstract][Full Text] [Related]
19. METTL3-mediated m6A mRNA methylation regulates neutrophil activation through targeting TLR4 signaling.
Luo S; Liao C; Zhang L; Ling C; Zhang X; Xie P; Su G; Chen Z; Zhang L; Lai T; Tang J
Cell Rep; 2023 Mar; 42(3):112259. PubMed ID: 36920907
[TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine modification positively regulate Japanese encephalitis virus replication.
Yao M; Cheng Z; Li X; Li Y; Ye W; Zhang H; Liu H; Zhang L; Lei Y; Zhang F; Lv X
Virol J; 2024 Jan; 21(1):23. PubMed ID: 38243270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
